IQVIA™ Real-World Insights Bibliography

Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy
Author(s): Udeh-Momoh CT, Watermeyer T, Price G, de Jager Loots CA, Reglinska-Matveyev N, Ropacki M, Ketter N, Fogle M, Raghavan N, Arrighi M, Brashear R, Di J, Baker S, Giannakopoulou P, Robb C, Bassil D, Cohn M, McLellan-Young H, Crispin J, Lakey K, Lisa C, Chowdary Seemulamoodi Y, Kafetsouli D, Perera D, Car J, Majeed A, Ward H, Ritchie K, Perneczky R, Kivipelto M, Scott D, Bracoud L, Saad Z, Novak G, Ritchie CW, Middleton L
Affiliations(s): Imperial College London
Publication(s):  BMJ Open
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Neurological disorders,
2021
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study
Author(s): Farah Toron 1, Maureen P Neary 2, Timothy W Smith 3, David Gruben 4, William Romero 5, Amy Cha 3, Keyur Patel 1, Simona Z Vasileva 6, Mahreen Ameen 7
Affiliations(s): 1Health Economics and Outcomes Research, Real World Solutions, IQVIA, 210 Pentonville Road, London, N1 9JY, UK. 2Inflammation & Immunology, Pfizer Inc, Collegeville, Pennsylvania, USA. 3Inflammation & Immunology, Pfizer Inc, New York, New York, USA. 4Global Biometrics and Data Management (Statistics), Pfizer Inc, Groton, Connecticut, USA. 5Inflammation & Immunology, Pfizer Ltd, Surrey, UK. 6Health Economics and Outcomes Research, Real World Solutions, IQVIA, 210 Pentonville Road, London, N1 9JY, UK. simona.vasileva@iqvia.com. 7Royal Free London National Health Services Foundation Trust, London, UK.
Publication(s):  PMID: 33846907 PMCID: PMC8163940 DOI: 10.1007/s13555-021-00519-7
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Dermatology, Drug Utlization Study, Methodology,
2021
  L:
A:
English
direct to patient research, direct-to-patient research, Economic evaluation, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
Author(s): Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy
Publication(s):  BMC Gastroenterology
BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Type(s): Article,
Countries: Australia, Canada, Italy, UK,
Click here for the abstract
C:
Y:
Oncology,
2020
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Nivolumab-treated non-small cell lung cancer patients in the United Kingdom
Author(s): Carroll R1, Tanna N1, Ghosh S2, Sanchez E3, Stawiarska Z4, Gemmen E5
Affiliations(s): 1 Bristol-Myers Squibb, Uxbridge, UK 2 IQVIA, Gurugram, India 3 IQVIA, Barcelona, Spain 4 IQVIA, Warsaw, Poland 5 IQVIA, Rockville, MD, US
Publication(s):  BMC Gastroenterology
Document Type(s): Article,
Countries: UK,
C:
Y:
Oncology,
2020
  L:
A:
English
Observational study, Population Based Study, Retrospective Field Study,
  Add to report
 
 
Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the Ninth Mount Hood Diabetes Challenge
Author(s): Si L, Willis MS, Asseburg C, Tew M, Clarke PM, Lamotte M, Ramos M, Hui S, Shi L, Zhang P, McEwan P, Ye W, Herman WH, Isaman DJ, Kuo S, Schramm W, Sailer F, Brennan A, Pollard D, Smolen HJ, Leal J, Gray A, Patel R, Feenstra T, Palmer AJ
Affiliations(s): IQVIA, Zaventem, Belgium and IQVIA, Lisbon, Portugal
Publication(s):  Value in Health
Document Type(s): Article,
Countries: UK,
C:
Y:
Diabetes,
2020
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Impact of using different types of hba1c progression in the IQVIA core diabetes model
Author(s): Ramos M1, Monteiro S2, Lamotte M1
Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK
Publication(s):  ISPOR US 2020 Orlando Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB52
Document Type(s): Article,
Countries: UK,
C:
Y:
Diabetes,
2020
  L:
A:
English
Population Based Study,
  Add to report
 
 
Does including acute pancreatitis as a complication have an impact on cost-effectiveness analyses using the IQVIA core diabetes model?
Author(s): Monteiro S1, Ramos M2, Lamotte M2
Affiliations(s): 1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium
Publication(s):  ISPOR US 2020 Orlando Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB52
Document Type(s): Article,
Countries: UK,
C:
Y:
Diabetes,
2020
  L:
A:
English
Population Based Study,
  Add to report
 
 
The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results
Author(s): Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8
Affiliations(s): 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands
Publication(s):  European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
Document Type(s): Poster,
Countries: Belgium, France, Germany, Italy, UK,
C:
Y:
Clinical practice, Public Health,
2020
  L:
A:
English
Population Based Study, Public Health, Retrospective database analysis,
  Add to report
 
 
Who owns patient data? The answer is not that simple
Author(s): Alison Bourke, Georgina Bourke
Affiliations(s): Scientific Director, Centre of Advanced Evidence Generation, IQVIA, and Past President of the International Society for Pharmacoepidemiology. Designer and Strategist at Projects by IF, a technology studio that focuses on the ethical and practical uses of data and AI.
Publication(s):  BJMOpinion August 6, 2020
Document Type(s): Article,
Countries: UK, USA,
Click here for the abstract
C:
Y:
COVID-19, Health policy,
2020
  L:
A:
English
Market impact,
  Add to report
 
 
Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study
Author(s): Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco D?Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5
Affiliations(s): 1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 Università Campus Bio-Medico di Roma, Rome, Italy
Publication(s):  COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020
Document Type(s): Poster,
Countries: Canada, Italy, UK,
C:
Y:
Hematology, Oncology,
2020
  L:
A:
English
Population Based Study,
  Add to report
 
 
 1 of 104 Next Page Last Page